Study authors said toripalimab plus chemotherapy could be a first-line treatment option, but authors of a related commentary ...

Equecabtagene autoleucel produced “remarkable” responses in patients whose disease progressed after prior BCMA CAR T-cell therapy, researchers reported.

Source: Getty Images Experienced dermatologists provide more accurate diagnoses than inexperienced dermatologists or primary care providers, and the use of in-person examination plus dermoscopy can ...

A decade ago, an old work injury put Fred Blackman II in the hospital with a slipped spinal disc that threatened to paralyze ...

Source: Getty Images “Targeted, culturally adapted clinical and public health interventions are needed to narrow disparities ...

Source: Getty Images Pegylated liposomal doxorubicin showed promise in a single-arm trial, but randomized trials are needed, ...

Source: Getty Images “Planning and evaluation for pregnancy and childbirth, including cryopreservation of eggs or embryos, ...

(HealthDay News) — Greater hospital COVID-19 burden is associated with an increased risk of in-hospital adverse events (AEs) among patients with and without COVID-19 in the United States, according to ...

Source: Getty Images “[T]he professional licensure system … may be institutionally ill-suited to combat the diffuse, intractable, and largely public health-related harms arising from physician-spread ...

Concurrent DNA and RNA sequencing revealed 15.3% more patients with actionable variants than DNA sequencing alone.

The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Patients with prostate cancer who undergo prostatectomy or radiotherapy have a higher risk of long-term complications than untreated patients with prostate cancer.